Non-bisphosphonates for treating osteoporosis [ID901]
Discontinued
Reference number: GID-TA10072
The Committee discussion scheduled for 7 January 2021 has been cancelled.
During the preparation for the Committee meeting, NICE has considered whether this appraisal will add value to the existing published guidance and how best to advise the NHS on the use of romosozumab.